NCT03486197 Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT03475953 A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT03473756 Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma Status COMPLETED Phase PHASE1
NCT03473743 A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03407976 Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies Status TERMINATED Phase PHASE1
NCT03399643 A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce) Status TERMINATED Phase N/A
NCT03397394 Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT03387761 Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy Status COMPLETED Phase PHASE1
NCT03330886 A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina Status COMPLETED Phase N/A
NCT03317158 Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03311334 A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03291028 Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03287050 Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT03280459 Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction Status UNKNOWN Phase N/A
NCT03272217 Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer Status TERMINATED Phase PHASE2
NCT03265080 A Study of ADXS-NEO Expressing Personalized Tumor Antigens Status TERMINATED Phase PHASE1
NCT03252938 Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03240016 Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer Status COMPLETED Phase PHASE2